Equities

BSF Enterprise PLC

BSFA:LSE

BSF Enterprise PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4.75
  • Today's Change0.00 / 0.00%
  • Shares traded397.84k
  • 1 Year change-58.15%
  • Beta1.2869
Data delayed at least 20 minutes, as of Jul 02 2024 13:47 BST.
More ▼

Profile data is unavailable for this security.

About the company

BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.

  • Revenue in GBP (TTM)67.24k
  • Net income in GBP-1.71m
  • Incorporated2018
  • Employees4.00
  • Location
    BSF Enterprise PLCGround Floor, 31 Old Burlington StreetLONDON W1S 3ASUnited KingdomGBR
  • Phone+44 20 3283 4590
  • Websitehttps://bsfenterprise.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Nuformix PLC0.00-341.86k1.43m2.001.43m2.00
N4 Pharma PLC1.95k-1.28m1.68m5.001.68m5.00
CRISM' Therapeutics Corp0.00-1.89m1.96m4.001.96m4.00
BSF Enterprise PLC67.24k-1.71m4.91m4.004.91m4.00
Oncimmune Holdings PLC1.21m-3.19m8.27m56.008.27m56.00
Kanabo Group PLC895.00k-7.99m9.17m20.009.17m20.00
Data as of Jul 02 2024. Currency figures normalised to BSF Enterprise PLC's reporting currency: UK Pound GBX
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.